Todd Asset Management LLC Makes New Investment in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Todd Asset Management LLC purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 131,208 shares of the company's stock, valued at approximately $10,145,000.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Commonwealth Equity Services LLC grew its holdings in GE HealthCare Technologies by 9.2% in the 3rd quarter. Commonwealth Equity Services LLC now owns 124,500 shares of the company's stock worth $8,471,000 after acquiring an additional 10,515 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its holdings in GE HealthCare Technologies by 69.0% during the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 78,493 shares of the company's stock valued at $5,341,000 after purchasing an additional 32,051 shares during the period. Robeco Institutional Asset Management B.V. raised its position in GE HealthCare Technologies by 10.8% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 103,284 shares of the company's stock valued at $7,027,000 after purchasing an additional 10,101 shares during the last quarter. Pinnacle Associates Ltd. lifted its holdings in GE HealthCare Technologies by 55.7% in the 3rd quarter. Pinnacle Associates Ltd. now owns 11,978 shares of the company's stock worth $815,000 after buying an additional 4,284 shares during the period. Finally, Raymond James & Associates lifted its holdings in GE HealthCare Technologies by 16.8% in the 3rd quarter. Raymond James & Associates now owns 329,514 shares of the company's stock worth $22,420,000 after buying an additional 47,456 shares during the period. 82.06% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

GEHC has been the subject of a number of recent analyst reports. Mizuho decreased their target price on GE HealthCare Technologies from $110.00 to $105.00 and set a "buy" rating for the company in a report on Wednesday. Argus raised their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a "buy" rating in a research report on Monday, April 1st. Morgan Stanley lifted their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an "equal weight" rating in a research note on Monday, February 12th. Citigroup raised their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a "buy" rating in a report on Wednesday, April 3rd. Finally, Evercore ISI upped their target price on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an "outperform" rating in a report on Thursday, April 4th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $95.00.

GE HealthCare Technologies Stock Up 2.1 %

NASDAQ:GEHC traded up $1.64 during trading hours on Friday, reaching $79.47. 2,722,865 shares of the company traded hands, compared to its average volume of 3,070,492. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11. The business's 50-day moving average price is $88.25 and its two-hundred day moving average price is $78.89. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.50. The stock has a market capitalization of $36.27 billion, a P/E ratio of 23.24, a P/E/G ratio of 2.80 and a beta of 1.26.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The firm had revenue of $4.65 billion during the quarter, compared to analyst estimates of $4.80 billion. During the same quarter in the previous year, the firm earned $0.85 EPS. GE HealthCare Technologies's quarterly revenue was down 1.2% compared to the same quarter last year. Analysts predict that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a dividend yield of 0.15%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.51%.

Insider Buying and Selling

In other GE HealthCare Technologies news, insider Frank R. Jimenez purchased 1,315 shares of the stock in a transaction dated Wednesday, May 1st. The shares were purchased at an average cost of $76.52 per share, with a total value of $100,623.80. Following the completion of the acquisition, the insider now directly owns 75,796 shares in the company, valued at approximately $5,799,909.92. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.27% of the stock is owned by company insiders.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.